UPC Analytics
DEEN
Übersicht · Eingereicht: —

UPC_CFI_723/2025

AUTOMATED MANAGEMENT OF CLINICAL MODIFICATIONS TO TREATMENT PLANS USING THREE-DIMENSIONAL CONTROLS

Einstweilige MaßnahmenEinstweilige MaßnahmenDusseldorf LDApplication for provisional measures—
ÜbersichtEntscheidungenBegründungZitateDokumenteZeitverlauf
Parteien

Kläger

  • Align Technology, Inc.
Vertreter: John Brunner (Carpmaels & Ransford LLP); Agathe Michel-De Cazotte (Carpmaels & Ransford LLP)

Beklagte

  • Angelalign Technology Inc.
  • Angelalign France Technology SASU
  • Europe Angelalign Technology B.V.
  • Angelalign Technology (Germany) GmbH
  • Italy Angelalign Technology S.R.L.
  • Shanghai EA Medical Instruments Co., Ltd.
Vertreter: Arno Riße (Arnold Ruess Rechtsanwälte Part mbB); Ulrich Storz (Michalski Hüttermann & Partner Patentanwälte mbB); Wanze Zhang (Michalski Hüttermann & Partner Patentanwälte mbB)
Richter
  • ThomasPresiding Judge
  • ThomLegally Qualified Judge
  • Marjolein VisserJudge-Rapporteur
  • PapaTechnically Qualified Judge
Patente
  • EP4346690
  • EP 4 346 690 B1
CPC-Codes: G16H50/50, A61C7/08, A61C9/004, A61C13/0004, G16H40/67, G16H30/20, G16H30/40, G16H50/70, A61C13/0019, B33Y80/00, A61C13/0006, G16H20/30…

Sektor: Healthcare Informatics

Ausgang
PI erteilt
Eingereicht: —
Erste Entscheidung: 6. Nov. 2025
Letzte Entscheidung: 12. Feb. 2026
Sprache: —

Düsseldorf Local Division granted provisional measures (preliminary injunction) against Angelalign defendants 1, 2, 4, 5, and 6 for infringement of EP 4 346 690 B1 (dental aligner technology), with penalty payments of up to EUR 10,000 per infringing product or EUR 20,000 per day for continuing infringement, and provisional cost reimbursement of EUR 400,000. The application against defendant 3 (Angelalign Technology Inc., Cayman Islands holding company) was rejected as no actions beyond typical shareholder role were alleged.